Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax. (Q47852201)

6 February 2018

title

Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax. (English)

1 reference

6 February 2018

0 references

2

1 reference

6 February 2018

Moriya Tsuji

6

1 reference

6 February 2018

Hernando A del Portillo Obando

1 reference

ORCID Public Data File 2021

author name string

de Oliveira CI

1

1 reference

6 February 2018

Levitus G

3

1 reference

6 February 2018

Soares IS

4

1 reference

6 February 2018

Rodrigues MM

5

1 reference

6 February 2018

del Portillo HA

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

17

1 reference

6 February 2018

issue

23-24

1 reference

6 February 2018

page(s)

2959-2968

1 reference

6 February 2018

Plasmodium vivax malaria: parasite biology defines potential targets for vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

1 reference

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Nucleic acid vaccination against Toxoplasma gondii in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Immunization against blood-stage rodent malaria using purified parasite antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Immunization against malaria with a recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Asexual blood stage vaccines: from merozoites to peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Pathways and strategies for developing a malaria blood-stage vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Plasmodium vivax: dimorphic DNA sequences from the MSP-1 gene code for regions that are immunogenic in natural infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900176-0

7 January 2021

10.1016/S0264-410X(99)00176-0

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

10462230

1 reference

6 February 2018